期刊文献+

胃肠内外间质瘤临床病理特征及预后比较分析 被引量:2

Analysis and comparison of the clinicopathological features and prognosis of gastrointestinal stromal tumor and extra-gastrointestinal stromal tumor
原文传递
导出
摘要 目的分析比较胃肠外间质瘤(EGIST)与胃肠间质瘤(GIST)的临床病理特征和预后差异。方法回顾性分析2011年1月至2018年8月经西南医科大学附属医院病理科确诊的33例EGIST和315例GIST病人的临床病理及预后资料。结果33例EGIST中男性11例(33.3%),女性22例(66.7%),发病年龄(53.2±13.1)岁;315例GIST中男性141例(44.8%),女性174例(55.2%),发病年龄(56.3±11.8)岁。与GIST病人相比,EGIST病人肿瘤直径更大(χ^(2)=24.644,P<0.001)、肿瘤易破裂(χ^(2)=5.534,P=0.019)、肿瘤易发生囊性变(χ^(2)=15.375,P=0.002)、核分裂象计数>5个/50HPF者更多(χ^(2)=24.867,P<0.001),NIH危险度分级更高(χ^(2)=39.583,P<0.001)。接受肿瘤切除术后,EGIST与GIST病人5年总生存率分别为55.3%、81.2%,5年无进展生存率分别为43.1%、74.6%,差异有统计学意义(P值均<0.001),EGIST病人的预后更差,并且更易复发转移(χ^(2)=11.418,P=0.005)。多因素分析显示肿瘤直径是影响EGIST组病人5年总生存率的独立因素(P=0.028)。结论与GIST病人相比,EGIST病人的肿瘤体积更大,更易发生破裂,核分裂象计数更高,高危险度者更多,预后更差,更易发生复发转移,而肿瘤直径是影响EGIST病人预后的独立因素。 Objective To analyze and compare the clinicopathological features and prognosis of extra-gastrointestinal stromal tumor(EGIST)and gastrointestinal stromal tumor(GIST).Methods The clinicopathological and prognostic data of 33 patients with EGIST and 315 patients with GIST admitted in Department of Pathology,the Affiliated Hospital of Southwest Medical University from January 2011 to August 2018 were analyzed retrospectively.Results There were 33 cases of EGIST,with 11 males(33.3%)and 22 females(66.7%),and the average onset age was 53.2±13.1 years.There were 315 cases of GIST with 141 males(44.8%)and 174 females(55.2%),and the average onset age was 56.3±11.8 years.Compared with the GIST patients,the EGIST patients accompanied with a larger tumor volume(χ^(2)=24.644,P<0.001),an easier rupture to tumor(χ^(2)=5.534,P=0.019),an easier cystic-change(χ^(2)=15.375,P=0.002),a higher mitotic figure(χ^(2)=24.867,P<0.001),and a higher NIH risk(χ^(2)=39.583,P<0.001).After tumor resection,the 5-year overall survival rates of EGIST and GIST patients were 55.3%and 81.2%respectively,and the 5-year progression-free survival rates were 43.1%and 74.6%respectively.Both difference had statistics significance(P<0.001).The EGIST patients were prone to recurrence and metastasis after operation(χ^(2)=11.418,P=0.005)with a poor prognosis.By multivariate analysis,the independent indicator for the 5-year overall survival was tumor diameter in the EGIST patients(P=0.028).Conclusion EGIST is prone to a large tumor volume,easy to rupture,a high mitotic figure,and a high NIH risk.After tumor resection,the 5-year survival rate and progression-free survival rate of EIGST patients are low;meanwhile the prognosis of EGIST patients is poor and those patients are more likely to recurrence and metastasis.Moreover,tumor diameter is an independent factor for the prognosis of EGIST patients.
作者 周晓青 段怡 黄冉 杨志惠 ZHOU Xiao-qing;DUAN Yi;HUANG Ran(Department of Pathology,the Affiliated Hospital of Southwest Medical University,Luzhou 646000,China)
出处 《中国实用外科杂志》 CAS CSCD 北大核心 2021年第5期565-569,共5页 Chinese Journal of Practical Surgery
基金 四川省科技厅科技计划项目(No.2018JY0398)。
关键词 胃肠间质瘤 胃肠外间质瘤 临床病理 预后 gastrointestinal stromal tumor extra-gastrointestinal stromal tumor clinicopathological feature prognosis
  • 相关文献

参考文献6

二级参考文献44

  • 1Zhao-Xia Jiang,Sheng-Jian Zhang,Wei-Jun Peng,Bao-Hua Yu.Rectal gastrointestinal stromal tumors:Imaging features with clinical and pathological correlation[J].World Journal of Gastroenterology,2013,19(20):3108-3116. 被引量:31
  • 2詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 3Corless CL, Barnett CM, Heinrich Me. Gastrointestinal stromal tumours: origin and molecular oncology [J]. Nat Rev Cancer, 2011, 11 (12): 865-878.
  • 4Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J]. Science, 1998, 279 (5350) : 577 -580.
  • 5Hirota S, Ohashi A, Nishida T, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors [J]. Gastro-enterology, 2003, 125 (3) : 660-667.
  • 6joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor [J]. Hum Pathol, 2008, 39 (10): 1411-1419.
  • 7Taylor ML, Metcalfe DD. Kit signal transduction [J]. Hematol Oncol Clin North Am, 2000, 14 (3) : 517 -535.
  • 8Doyle LA, Hornick JL. Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase [J]. Histopathology, 2014, 64 (1) : 53-67.
  • 9BUmming P, Ahlman H, Andersson J, et al. Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours [J]. Br J Surg, 2006, 93 (7): 836-843.
  • 10Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis [J]. Arch Pathol Lab Med, 2006, 130 (10): 1466-1478.

共引文献205

同被引文献15

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部